Medical Condition News

RSS

$11.5 million grant to Mayo Clinic Cancer Center to translate research into treatments for women with ovarian cancer

Investigators at the Mayo Clinic Cancer Center have received a five-year, $11.5 million grant to translate research into treatments for women with ovarian cancer.

28 Aug 2009

Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures

A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.

28 Aug 2009

New technology based on the Lombard effect for improving speech and voice in Parkinson's patients

Researchers have developed a new technology that helps Parkinson's patients overcome the tendency to speak too quietly by playing a recording of ambient sound, which resembles the noisy chatter of a restaurant full of patrons.

28 Aug 2009

Arno Therapeutics to commence Phase 1 clinical study of AR-12 in adult patients with lymphoma

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first patient in a Phase I clinical study of AR-12 (formerly OSU-03012) in adult patients with advanced or recurrent solid tumors or lymphoma.

28 Aug 2009

$3 million grant to help Parkinson's Institute and Clinical Center to continue cutting-edge research

The Parkinson's Institute and Clinical Center (PI) is very excited to announce the receipt of a $3 million challenge grant from the Brin Foundation as the lead gift in the PI's $15 million Capital Campaign - "A Campaign to Conquer Parkinson's Disease." The "Challenge" feature of the grant invites individuals, foundations and corporations to partner with the Brin Foundation in support of Parkinson's research.

28 Aug 2009

Research finds that people with psoriasis are less likely to react to looks of disgust by others

People with psoriasis - an often distressing dermatological condition that causes lesions and red scaly patches on the skin - are less likely to react to looks of disgust by others than people without the condition, new research has found.

From The University of Manchester 27 Aug 2009

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

27 Aug 2009

New study of diabetes patients across five European countries launched by GfK Healthcare

GfK Healthcare’s Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five European countries, with robust insights into patients’ attitudes and behaviors towards treatments, testing and lifestyles, the study now makes available to marketers greater reporting frequency and focus across a variety of broad-based and niche diabetes patient groups.

27 Aug 2009

Study suspects involvement of PPAR-γ in gastric carcinogenesis

Recently, the potential of PPAR-γ as a target for the prevention and treatment of cancer has been widely studied. However, the potential therapeutic role of PPAR-γ agonists has been questioned, based on contradictory results. Studies using animal models of colon cancer found that PPAR-γ agonists increased the development of colon tumors.

27 Aug 2009

New genetic mechanism to control body's fat-building process identified

At a time of alarming increases in obesity and associated diseases -- and fiery debates about the cost of health care -- a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.

27 Aug 2009

Kudzu vine root extracts may be developed as a dietary supplement for people with metabolic syndrome

Kudzu, the nuisance vine that has overgrown almost 10 million acres in the southeastern United States, may sprout into a dietary supplement.

27 Aug 2009

GI Dynamics to present additional results of mechanisms of actions clinical study

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.

27 Aug 2009

Significant drop in prevalence of rheumatoid vasculitis between 2000 and 2001

Researchers at the University of Wisconsin School of Medicine and Public Health examined records of rheumatoid arthritis (RA) patients from the national Veterans Health Administration (VHA) system to determine the prevalence of rheumatoid vasculitis (RV) in this population. The study found a downward trend in the number of RA patients who go on to develop RV, with a significant drop of 53% among inpatients and 31% among outpatients between 2000 and 2001.

27 Aug 2009

Prevention and eradication of FVIII antibodies could improve hemophilia treatment

Octapharma AG is leading an international initiative focused on confronting the major risk associated with hemophilia A therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors. This initiative, combined with Octapharma's efforts to pursue the first recombinant FVIII therapy produced from a human cell line, could dramatically impact the treatment of an estimated one in every 5,000 to 10,000 men born with hemophilia A worldwide.

27 Aug 2009

Wellness International Network's BioLean Free help fight obesity

The global obesity epidemic continues to increase, especially in the United States. In fact, the number of obese American adults (34.3 %) exceeds the number of overweight adults (32.7%), says a 2008 study by the National Center for Health Statistics. Wellness International Network, an undisputed nutritional leader, is helping fight these statistics with its weight-management product line and recently unveiled modern, attractive packaging for one of its bestselling, weight-management products BioLean Free.

27 Aug 2009

Ontario Expert Panel releases practical recommendations for couples facing adoption and infertility problems

The Ontario Expert Panel on Infertility and Adoption has released many practical recommendations to government in a report entitled "Raising Expectations." Following the mammoth job of reviewing the issues surrounding infertility treatment and adoption, the panel's report lays out a comprehensive plan to address several pressing social concerns.

27 Aug 2009

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation

In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading causes of cancer death in the world.

27 Aug 2009

Kansas City Cancer Center uses radiation therapy for cancer treatments

Kansas City Cancer Center (KCCC), an affiliate of US Oncology, Inc. which supports the nation's foremost cancer treatment and research network, has treated its first patient with the new TomoTherapy(R) radiation therapy technology at its new KCCC-Shawnee Mission office.

27 Aug 2009

Link between collagen deficiency and osteoarthritis found in mice

Osteoarthritis (OA) and degenerative disc disease (DDD) are common, chronic musculoskeletal disorders. Both diseases cause joint pain, loss of function, and decreased quality of life for the more than 27 million OA and 59 million DDD suffers in the US. According to a 2003 Medical Expenditure Panel Survey, arthritis such as OA costs the U.S. economy nearly $128 billion per year in medical care and indirect expenses including lost wages and productivity.

27 Aug 2009

Fight against brain tumor will result in greater awareness and positive outcomes

With this morning's passing of Massachusetts Senator Ted Kennedy from a brain tumor, Wilmington's Christopher Grundner says he feels that it could lead to quicker diagnoses for others affected by the disease and more support for the cause.

27 Aug 2009

Medical Condition News

$11.5 million grant to Mayo Clinic Cancer Center to translate research into treatments for women with ovarian cancer

Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures

New technology based on the Lombard effect for improving speech and voice in Parkinson's patients

Arno Therapeutics to commence Phase 1 clinical study of AR-12 in adult patients with lymphoma

$3 million grant to help Parkinson's Institute and Clinical Center to continue cutting-edge research

Research finds that people with psoriasis are less likely to react to looks of disgust by others

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

New study of diabetes patients across five European countries launched by GfK Healthcare

Study suspects involvement of PPAR-γ in gastric carcinogenesis

New genetic mechanism to control body's fat-building process identified

Kudzu vine root extracts may be developed as a dietary supplement for people with metabolic syndrome

GI Dynamics to present additional results of mechanisms of actions clinical study

Significant drop in prevalence of rheumatoid vasculitis between 2000 and 2001

Prevention and eradication of FVIII antibodies could improve hemophilia treatment

Wellness International Network's BioLean Free help fight obesity

Ontario Expert Panel releases practical recommendations for couples facing adoption and infertility problems

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation

Kansas City Cancer Center uses radiation therapy for cancer treatments

Link between collagen deficiency and osteoarthritis found in mice

Fight against brain tumor will result in greater awareness and positive outcomes

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Latest News